Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Ticker BSX · NYSE · DE
BOSTON SCIENTIFIC CORP is a U.S. business entity operating within the Surgical & Medical Instruments & Apparatus sector (SIC 3841). Publicly traded on the NYSE under the ticker symbol BSX, the company is incorporated in Delaware. Based on SEC EDGAR filings, BSX reported fiscal year 2025 revenue of $20.07B, reflecting a year-over-year growth of 19.9%. Our proprietary Semantic Risk Score of 14 indicates high transparency and low reporting risk, derived from the frequency and consistency of 10-K, 10-Q, and 8-K filing patterns. As part of the SIC 3841 classification, BOSTON SCIENTIFIC CORP serves as a key benchmark for investors and analysts monitoring Delaware corporate performance.
Comparison based on Standard Industrial Classification (SIC) mapping from SEC EDGAR filings.
Filing data sourced from SEC EDGAR signals. 10-K = annual report · 10-Q = quarterly · 8-K = material event.
BOSTON SCIENTIFIC CORP (BSX) — Key efficiency & solvency metrics · FY2025
Operating Margin
Sector avg: -25.81%
Net Margin
Sector avg: -40.06%
Debt-to-Equity
Sector avg: 2.45
Current Ratio
Sector avg: 3.95
| Key Metric | Company | Industry Avg | Status |
|---|---|---|---|
| Total RevenueYoY: +19.9% | $20.07B | $1.38B | ▲ Outperform |
| Operating MarginOperating income as % of revenue | 18% | -25.81% | ▲ Outperform |
| Net MarginNet income as % of revenue | 0% | -40.06% | ▲ Outperform |
| Debt-to-EquityTotal liabilities / stockholders equity. Lower = safer. | 1.8 | 2.45 | ▲ Stable |
| Current RatioCurrent assets / current liabilities. Above 1.0 = solvent. | 1.62 | 3.95 | ▼ Lagging |
Source: SEC EDGAR XBRL filings (10-K annual reports). Industry benchmarks derived from 116 companies in SIC 3841.
Disclaimer: All financial data is sourced from raw SEC EDGAR filings. Sprytne.com provides automated data visualization and algorithmic analysis for informational purposes only. This is NOT financial advice, a recommendation to buy/sell, or a guarantee of accuracy. Always verify data via official SEC sources before making investment decisions.
Federal Contracts
THERASPHERE
THERASPHERE Y-90 GLASS MICROSPHERE MEDICATION
Y90 GLASS MICROSPHERES
STENT CONSIGNMENT
IGF::OT::IGF -MEDICAL SUPPLIES
EXPRESS REPORT: BOSTON SCIENTIFIC CONSIGNMENT AGREEMENT EXPENDITURES.
LEFT ATRIAL APPENDAGE CLOSURE DEVICES&ACCESSORIES
Y90 THERASPHERE
EXPRESS REPORT FOR PROSTHETICS VA MEDICAL CENTERS IN VISN 12 537-1Q0039 537-1Q0041 537-1Q0113 537-1Q0819 537-1Q0821 537-1Q0824 537-1Q0958 537-1Q1112 537-1Q1211 537-1Q1320 537-1Q1321 537-1Q1654 537-1Q2014 537-1Q2016 537-Q10536 537-Q10560 537-Q10795 537-Q10991 537-Q10992 537-Q11209 537-Q11249 537-Q11988 537-Q11993 537-Q11994 537-Q12520 537-Q12521 537-Q12630 537-Q12778 537-Q12795 537-Q12803 537-Q12955 537-Q13076 537-Q13478 537-Q13947 537-Q13948 537-Q14196 537-Q14314 537-Q14335 537-Q15030 537-Q15676 537-Q15699 537-Q15800 537-Q16080 537-Q16131 537-Q16157 537-Q16266 537-Q16311 537-Q16500 537-Q16556 537-Q17010 537-Q17157 537-Q17390 537-Q17650 537-Q17657 537-Q17663 537-Q17664 537-Q17859 537-Q18081 537-Q18083 537-Q18095 537-Q18678 537-Q19036 537-Q19151 537-Q19315 537-Q19337 537-Q19720 578-Q16458 607-Q10018 607-Q10133 607-Q10318 607-Q10338 607-Q10352 607-Q10743 607-Q10814 607-Q10815 607-Q10816 607-Q10817 607-Q10948 607-Q11083 607-Q11247 607-Q11252 607-Q11427 607-Q11594 607-Q11670 607-Q11678 607-Q11679 607-Q11709 607-Q11725 607-Q11973 607-Q12018 607-Q12191 607-Q12268 607-Q12447 607-Q12632 607-Q12633 607-Q12673 607-Q12675 607-Q12677 607-Q12692 607-Q12725 607-Q12737 607-Q12739 607-Q12742 607-Q12874 607-Q12905 607-Q12910 607-Q13116 607-Q13117 607-Q13483 607-Q13701 607-Q13943 607-Q13967 607-Q13968 607-Q13970 607-Q14042 607-Q14110 607-Q14154 607-Q14177 607-Q14261 607-Q14602 607-Q14624 607-Q14636 607-Q14868 607-Q14890 607-Q14994 607-Q15244 607-Q15251 607-Q15299 607-Q15374 607-Q15444 607-Q15632 607-Q15740 607-Q15742 607-Q15798 607-Q15809 607-Q15858 607-Q16228 607-Q16230 607-Q16368 607-Q16369 607-Q16370 607-Q16491 607-Q16692 607-Q16703 607-Q16723 607-Q16775 607-Q16808 607-Q17092 607-Q17093 607-Q17299 607-Q17404 607-Q17555 607-Q17983 607-Q18258 607-Q18341 607-Q18550 607-Q18552 607-Q18690 695-1Q2974 695-1Q3544 695-1Q3933 695-1Q4689 695-1Q6104 695-1Q6335 695-1Q7655 695-1Q7665 695-1Q9569 695-1Q9622 695-Q10410 695-Q10636 695-Q10890 695-Q10981 695-Q11528 695-Q11696 695-Q12486 695-Q12566 695-Q12847 695-Q12933 695-Q13309 695-Q16198 695-Q18224 695-Q18966 695-Q19245
YTTRIUM-90 THERASPHERES
Source: USAspending.gov (Official Federal Award Data). Reflects prime contracts only. Last sync: 2026-03-30.
Compared to 151 peers in Surgical & Medical Instruments & Apparatus (SIC 3841)
Revenue
SEC EDGAR XBRL filings by fiscal year
Side-by-side financial showdown — revenue, margins, and growth.
Methodology & compliance note
Data is aggregated from SEC EDGAR and Secretary of State public records. Any analytics such as "market share" are statistical estimates (proxy models) and are not official audits, valuations, or investment advice. Sprytne.com is an independent data aggregator and is not affiliated with any government agency.Learn more →